Anavex Life Sciences Corp (AVXL)

[Jonjones325]

This is an interesting thought. You are correct. Part C results are the validation of Ariana's analysis.

Hopefully we see some details at the CTAD. Choosing additional patients to replace the ones that dropped out using their data to select them would indeed be a homerun.

You would think Missling and the gang have explored this considering the amount of flexibility they have.

Secret early phase 3? That's a wild idea. Anything is possible.